StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories interest Expense ($M) ($M)

Postgres DB financial_values + XBRL

QuarterlyAnnual
Latest, Q2 2026
351
Period ended Jun 30, 2026
Change on a year earlier
+190.1%
121 in Q2 2025
History
73 quarters
Since Q2 2008
Sources
64
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInterest Expense ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026351+190.1%Form 10-Q (filed 2026-07-28) ↗
Q1 2026Mar 31, 2026174+32.8%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025120-11.8%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 2025121-14.8%Form 10-Q (filed 2025-10-29) ↗
Q2 2025Jun 30, 2025121-13.6%Form 10-Q (filed 2025-07-30) ↗
Q1 2025Mar 31, 2025131-7.1%Form 10-Q (filed 2025-04-30) ↗
Q4 2024Dec 31, 2024136-14.5%Form 10-K (filed 2025-02-21) ↗
Q3 2024Sep 30, 2024142-14.5%Form 10-Q (filed 2024-10-31) ↗
Q2 2024Jun 30, 2024140-11.9%Form 10-Q (filed 2024-07-31) ↗
Q1 2024Mar 31, 2024141-7.8%Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 2023159+3.2%Form 10-K (filed 2024-02-16) ↗
Q3 2023Sep 30, 2023166+17.7%Form 10-Q (filed 2023-11-01) ↗
Q2 2023Jun 30, 2023159+20.5%Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 2023153+16.8%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 2022154+17.6%Form 10-K (filed 2023-02-17) ↗
Q3 2022Sep 30, 2022141+6.0%Form 10-Q (filed 2022-11-01) ↗

Cite this data

StockData. (2026). Abbott Laboratories Interest Expense ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-is-int-exp

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.